Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Drugs Dermatol. 2012 Mar;11(3):413-4.

Long-term etanercept use for severe generalized psoriasis in an HIV-infected individual: a case study.

Author information

  • 1University of California, San Francisco, Department of Dermatology, USA. ericslee@gmail.com

Abstract

The treatment options for psoriasis in HIV-infected individuals are limited due to the immunosuppressive nature of the therapeutic modalities and the patient's immunocompromised state. Etanercept has been shown to be safe and effective in the non-HIV psoriasis population with nearly 20 years of experience. However, there is limited data on the safety of etanercept use in the HIV patient population. The authors report a case of an HIV-infected patient with psoriasis who has remained mostly clear on continuous, uninterrupted etanercept use for over six years.

PMID:
22395596
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk